BBIO

NASDAQ HEALTHCARE

BridgeBio Pharma Inc

$65.57

-$0.71 (-1.07%)

Live quote

52w: $50.50 – $93.42

Loading chart…

P/E Ratio—

P/B Ratio—

EV/EBITDA—

Debt/Equity—

ROE—

ROIC—

Revenue Growth126.26%

Gross Margin—

BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases. The company is headquartered in Palo Alto, California.

Own BBIO? Track it here.

Create a free account to add BBIO to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account